Article
Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
Pharmacopsychiatry - 1 Sept 2022
Esen-Sehir Dilhan, Kopf Juliane, Hägele Sandra, Plichta Michael M, Reif Andreas, Freudenberg Florian
Abstract excerpt
INTRODUCTION: The variants of the gene for nitric oxide synthase 1 adaptor protein (NOS1AP) are associated with schizophrenia and cardiovascular deficits involving corrected QT (QTc) interval prolongation. Here, we investigated a possible pharmacogenetic effect of antipsychotic treatment on QTc length in interaction with two NOS1AP variants (rs12143842 and rs10494366) whose minor alleles are associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
